;
Skip to main content
Home > Week in Review > Deals

Chronological Index of : Deals

 Current Issue
  • Albany Molecular Research, Cedarburg Hauser deal

    Albany Molecular Research Inc. (NASDAQ:AMRI), Albany, N.Y. Cedarburg Hauser Pharmaceuticals Inc., Grafton, Wis. Business: Supply/Service Albany Molecular completed its acquisition of contract developer and manufacturer …

    Published on 4/14/2014
  • Alexander David Investments plc, Tiziana Pharma Ltd. deal

    Alexander David Investments plc (LSE:ADI), London, U.K. Tiziana Pharma Ltd., London, U.K. Business: Cancer Alexander David Investments (ADI) will reverse-merge with Tiziana in a deal that values Tiziana at 7.5 million…

    Published on 4/14/2014
  • Ampio, Endo deal

    Ampio Pharmaceuticals Inc. (NYSE-M:AMPE), Greenwood Village, Colo. Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Business: Genitourinary Ampio's Vyrix Pharmaceutical Inc. subsidiary granted Endo's …

    Published on 4/14/2014
  • Asahi Kasei Pharma, RaQualia deal

    Asahi Kasei Pharma Corp., Tokyo, Japan RaQualia Pharma Inc. (JASDAQ:4579), Aichi, Japan Business: Pharmaceuticals Asahi and RaQualia partnered to discover therapeutic compounds targeting an undisclosed ion channel. The …

    Published on 4/14/2014
  • Aveo Pharmaceuticals, Biodesix deal

    Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Cambridge, Mass. Biodesix Inc., Broomfield, Colo. Business: Pharmacogenetics The companies partnered to develop and commercialize Biodesix's VeriStrat as a companion diagnostic …

    Published on 4/14/2014
  • Bio-Techne, CyVek deal

    Bio-Techne (NASDAQ:TECH), Minneapolis, Minn. CyVek Inc., Wallingford, Conn. Business: Diagnostic Research supply company Bio-Techne invested $10 million in diagnostics company CyVek for a 20% stake and received the …

    Published on 4/14/2014
  • Daiichi Sankyo, University of California deal

    Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan University of California, San Francisco, Calif. Business: Neurology, Diagnostic Daiichi partnered with UCSF to discover and develop novel drugs and diagnostics for …

    Published on 4/14/2014
  • Fairjourney Biologics, Hadassah University Hospitals, Rappaport Family Institute for Research in the Medical Sciences deal

    Fairjourney Biologics, Porto, Portugal Hadassah University Hospitals, Jerusalem, Israel Rappaport Family Institute for Research in the Medical Sciences, Haifa, Israel Business: Cancer Fairjourney Biologics partnered …

    Published on 4/14/2014
  • Ferring, Merck, World Health Organization (WHO) deal

    Ferring Pharmaceuticals A/S, Saint-Prex, Switzerland Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. World Health Organization (WHO), Geneva, Switzerland Business: Hematology The partners entered a deal to advance…

    Published on 4/14/2014
  • Genentech, Roche, PatientsLikeMe Inc. deal

    Genentech Inc., South San Francisco, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland PatientsLikeMe Inc., Cambridge, Mass. Business: Cancer Roche's Genentech unit partnered with PatientsLikeMe to develop a …

    Published on 4/14/2014
  • Genmab, Roche deal

    Genmab A/S (CSE:GEN; OTCBB:GMXAY), Copenhagen, Denmark Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Pharmacogenetics Roche's Ventana Medical Systems Inc. unit partnered with Genmab to develop an …

    Published on 4/14/2014
  • GlaxoSmithKline, University of Texas MD Anderson Cancer Center deal

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. University of Texas MD Anderson Cancer Center, Houston, Texas Business: Cancer The center partnered with GlaxoSmithKline to develop immunotherapies for cancer …

    Published on 4/14/2014
  • IntegraGen, Pfizer deal

    IntegraGen S.A. (Euronext:ALINT), Evry, France Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Diagnostic IntegraGen said it granted Pfizer access to evaluate IntegraGen's 56-gene molecular signature to predict …

    Published on 4/14/2014
  • IQuum, Roche deal

    IQuum Inc., Marlborough, Mass. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic, Supply/Service Roche will acquire molecular diagnostics company IQuum for $275 million in cash up front and up to $…

    Published on 4/14/2014
  • Mallinckrodt, Questcor deal

    Mallinckrodt plc (NYSE:MNK), ST. Louis, Mo. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR), Anaheim, Calif. Business: Autoimmune, Inflammation Specialty pharma Mallinckrodt will acquire Questcor in a cash and stock deal …

    Published on 4/14/2014
  • Marina Biotech, Rosetta Genomics deal

    Marina Biotech Inc. (Pink:MRNA), Bothell, Wash. Rosetta Genomics Ltd. (NASDAQ:ROSG), Rehovot, Israel Business: Neurology, Diagnostic The companies partnered to discover and develop microRNA-based products to diagnose …

    Published on 4/14/2014
  • Mersana, Takeda deal

    Mersana Therapeutics Inc., Cambridge, Mass. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Cancer Mersana will use its Fleximer polymer technology to create antibody-drug conjugates (ADCs) comprised…

    Published on 4/14/2014
  • Mesoblast, Osiris deal

    Mesoblast Ltd. (ASX:MSB; Pink:MBLTY), Melbourne, Australia Osiris Therapeutics Inc. (NASDAQ:OSIR), Columbia, Md. Business: Transplant, Gene/Cell therapy Osiris said it received $15 million in cash from Mesoblast under a…

    Published on 4/14/2014
  • Oricula Therapeutics, University of Washington deal

    Oricula Therapeutics LLC, Seattle, Wash. University of Washington, Seattle, Wash. Business: Other Oricula announced it received exclusive, worldwide rights to IP from the university covering compounds to preserve …

    Published on 4/14/2014
  • Oryzon, Roche deal

    Oryzon Genomics S.A., Barcelona, Spain Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Hematology, Cancer Oryzon Genomics granted Roche exclusive, worldwide rights to develop and commercialize a program of …

    Published on 4/14/2014
  • Ranbaxy, Sun Pharmaceutical deal

    Ranbaxy Laboratories Ltd. (NSE:RANBAXY; BSE:500359), Gurgaon, India Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA), Mumbai, India Business: Generics Sun will acquire fellow Indian generics company …

    Published on 4/14/2014
  • Seattle Genetics, Takeda deal

    Seattle Genetics Inc. (NASDAQ:SGEN), Bothell, Wash. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Cancer Seattle Genetics will receive $6 million in milestone payments from Takeda under a 2009 deal…

    Published on 4/14/2014
  • Seek Ltd., ValiRx deal

    Seek Ltd., London, U.K. ValiRx plc (LSE:VAL), London, U.K. Business: Cancer ValiRx and Seek's Tangent Reprofiling Ltd. subsidiary established a risk-sharing JV, ValiSeek Ltd., to develop Tangent's cancer candidate …

    Published on 4/14/2014
  • Shape Pharmaceuticals, TetraLogic deal

    Shape Pharmaceuticals Inc., Cambridge, Mass. TetraLogic Pharmaceuticals Corp. (NASDAQ:TLOG), Malvern, Pa. Business: Cancer Oncology and infectious diseases company TetraLogic will acquire Shape for $13 million up front …

    Published on 4/14/2014
  • Spero Therapeutics, Roche deal

    Spero Therapeutics LLC, Cambridge, Mass. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Infectious Infectious disease play Spero granted Roche the exclusive option to acquire Spero's lead antibiotic program,…

    Published on 4/14/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993